Listen & Watch

1. Unlocking The Future: Innovations In The mRNA And Oligo Supply Chains 11/12/2025

   In this forward-looking Advancing RNA event we explore the current and next generation of raw materials shaping the mRNA and oligo therapeutics landscapes. We've brought together industry leaders to discuss advancements in raw materials, including novel enzymes, optimized capping reagents, and other essential materials. We look at how the current generations of materials are informing the quality of our mRNA and oligo products, while also exploring how each sector of the RNA industry is working with next-gen raw materials to reduce COGS and improve manufacturing efficiency, product quality, and supply chain resilience. 

2. Process Development Considerations For Next-Gen RNA Therapeutics 9/24/2025

   As additional mRNA therapeutics makers progress toward and into the clinic, we've begun to gather more knowledge about what makes our mRNA products "tick," and how our processes impact the overall quality of our products.

3. RNA Delivery Reimagined: Innovative Nonviral Strategies Beyond LNPs 7/9/2025

   In this Advancing RNA Live, our editorial and community director Anna Rose Welch was joined by several leaders in the world of nucleic acid nonviral delivery beyond the “tried-and-true” LNP.

4. Understanding The Impact Of New Regulatory Guidance 5/19/2025

   In this Advancing RNA Live discussion, editorial and community director Anna Rose Welch sat down with CureVac’s Ulrike Jägle and Eliquent Life Science’s Tiffany Lucas to take a closer look at the latest mRNA regulatory guidance. They identified the biggest challenges the industry faced in navigating these guidances and explored the overarching learnings and best practices mRNA developers could apply across their programs, regardless of therapeutic approach.

5. A Closer Look At mRNA-LNP Analytical & Manufacturing Technology Innovation 4/29/2025
6. The "Tides" Have Changed: Outsourcing Oligos And Peptides 3/26/2025

   Shifting demand for oligos and peptides drove innovation in CDMO partnerships and reshaped outsourcing relationships. In this Outsourced Pharma Live panel, industry experts shared best practices for outsourcing these specialized therapeutics, with a focus on capacity, regulatory challenges, and technology transfer.

7. Accelerating mRNA-LNP Development: A Deep Dive Into Analytical & Manufacturing Technology Innovation 3/13/2025

   Advancing RNA Live tackled the challenges of mRNA-LNP CQAs head-on, exploring innovative ways to streamline development and enhance quality at smaller scales.

8. A Deep(er) Dive Into The mRNA/RNA-LNP Outsourcing Paradigm 2/27/2025
9. Navigating The Outsourcing Paradigm For RNA Modalities 1/21/2025

   Though there are an increasing number of CDMOs with mRNA/RNA capabilities/platforms, many of these are better equipped for large-scale, linear mRNA development. In this Advancing RNA Live panel discussion, we explored the state of the outsourcing industry and how mRNA and next-gen RNA modality companies need to evaluate CDMO partners' platforms and technical capabilities today.

10. Achieving Next-Generation mRNA-LNP Therapeutics Delivery 11/6/2024

    It’s impossible to attend an event on the future of RNA therapeutics without hearing about the challenges we’re facing with targeted RNA-LNP delivery. In this final Advancing RNA Live discussion of 2024, we sat down with three LNP experts to parse out the current opportunities and unknowns facing the development of next-generation LNPs.